Difference between revisions of "Team:Toulouse France/Experiments"

Line 100: Line 100:
 
<div class="column full_size" id="predation" style="background-color:#F5F5F5;">
 
<div class="column full_size" id="predation" style="background-color:#F5F5F5;">
 
 
<br>The predation module was composed of genes from <i>B. subtilis</i>, so we expected it to be expressed only in these bacteria. We designed the operons and made it synthetize. Considering their sizes, we could not obtain them at once and we had to divide them in blocks of two kilobase pairs. From there, our strategy was to do Gibson cloning to obtain the full operons in <i>E. coli</i> and then transfer them in <i>B. subtilis</i>. We managed to obtain the sdp operon but could not transform bacteria with it, probably because it produces a toxin active against <i>E. coli</i>. With more time, we should have been capable of integrate it in a <i>Bacillus</i> plasmid.
+
<div style="padding-top:30px; padding-left: 10%; padding-right: 10%;">
<br><br>Photo du gel
+
<div class="hoc container clear">
 +
 +
<b style="font-size:18px;">Predation</b><br><br>
 +
Our aim is to reinforce the natural predation capacity of B. subtilis and to ensure it is constant. We
  
<br><br>We elaborate a protocol and did the preliminary tests needed to evaluate the predatory response of <i>B. subtilis</i>. We tested the predation of <i>B. subtilis</i> Wild Type against <i>Pseudomonas fluorescens</i> with three different approaches.
+
first assessed that our wild type Bacillus chassis is not able of predation, then we built the operons
<br>First, we aimed to demonstrate <i>B. subtilis</i> was able feed on <i>P. fluorescens</i> and grow with it as sole source of nutrients. Therefore, after an overnight growth of both strains in rich medium, we put them in co-culture in minimal medium and monitored their growth rate all along the day. We saw no growth when doing it with <i>B. subtilis</i> WT.
+
  
<br><br>Then, we did a test on solid medium using cellulose disks soaked in a <i>B. subtilis</i> culture. We displayed them on plates containing a minimal medium seeded with <i>P. fluorescens</i>. If <i>B. subtilis</i> were capable of predation, it would have grown with the nutrients furnished by <i>P. fluorescens</i> lysis, but we observed nothing like that with <i>B. subtilis</i> WT.
+
allowing boosting the predation property.
<br>Finally, we wanted to test the efficiency of the lysis proteins produced by the bacteria. To do so, we put <i>B. subtilis</i> WT in rich medium to let it express the killing factor and delay protein. Then, we discarded the cells themselves thanks to a centrifugation and put this supernatant in contact with <i>P. fluorescens</i> for twenty minutes. At last, we spread the <i>Pseudomonas</i> on plates of rich medium and let them grow. We compared the growth of cells in contact with the <i>B. subtilis</i> supernatant with the one of cells that did not go through any treatment. With <i>B. subtilis</i> WT, we saw no differences.
+
<br><br>
</div>
+
+
<b style="font-size:16px;">Preliminary tests:</b>
<div class="column full_size" id="antifongique" style="background-color:#F5F5F5;">
+
<br><br>We tried different testing approaches to evaluate the predatory response of B. subtilis and eventually elaborate a protocol to do the preliminary test. We tested the predation of B. subtilis Wild Type against Pseudomonas fluorescens, a deleterious strain present in the cave. Briefly, the protocol consists in growing both strains in rich medium, mixing them in PBS and monitoring their growth (figure 1).  
  
<b>Demonstrate :</b>
+
<!-- ######  FIGURE  ##### -->
 +
<center><img src="https://static.igem.org/mediawiki/2016/d/d1/Toulouse_France_resultpredation.jpg" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 1: Bacillus subtilis wild type does not feed on Pseudomonas fluorescens. Both strain were grown overnight in rich medium and then mixed in PBS. The growth of both strains were then monitored for 8 hours by plate numeration. The graph represents the ratio between B. subtilis in PBS in presence of P. fluorescens  versus B. subtilis alone in PBS (data normalized to time 1H). </b>
 +
<br><br>
 +
 +
We observed no growth benefit when mixing B. subtilis and P. fluorescens versus B. subtilis alone. We conclude that B. subtilis WT predation program is not the strain priority when facing starvation. Other surviving program as competence or sporulation are likely favoured by B. subtilis in such condition. This reinforces the need to prevent these programs by using a spoOA mutant and to promote the predation by overexpressing either the SKF or SDP operons.
 +
<br><br>
 +
 +
<b style="font-size:16px;">SKF</b>
 +
<br><br>
 +
This predation operon is composed of 7 genes for a total of more than 6 Kb. To get rid of restriction sites that could interfere with the cloning steps, we ordered the optimized sequences from IdT as 4 gblocks. From there, our strategy was to do Gibson cloning to obtain the full operon on pSB1C3 in E. coli and then to transfer it in B. subtilis. However, we did not manage to obtain the whole assembly (figure 2), neither partial ones, in spite of about 20 attempts…
 +
 +
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 2 : Layout of SKF expected biobrick.
 +
<br><br>
 +
 +
<b style="font-size:16px;">SDP</b>
 +
<br><br>
 +
The SDP operon is smaller than the SKF one and it was possible to obtain the optimized sequences as two gblocks. Here again, we were unfortunate and did not get the expected clones in E. coli (figure 3).
 +
 +
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 3 : Layout of SDP expected biobrick.
 +
<br><br>
 +
 +
To perform trouble shooting, we try an assembly test with just the two gblocks and deposited the product on gel. We observed that the reaction seems to be effective with the presence of a new band corresponding to the combined size of the two gblocks (figure 4).
  
<br><br>Since its opening the Lascaux cave frescos are under different fungi’s threat. Conventional treatment have already been tested over the years, they did not work in the long term. It lets the microbiom empty which stimulated the development of other contaminations as fungi.
+
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 4: Gibson assemby of the two SDP Gblocks.
 +
<br><br>
  
<br><br>For this competition we decided to develop an experimental fungal control with a bacteria Bacillus subtilis. This strain is able to produce anti fungal compounds in response to N-acetyl-glucosamin, an important fungi cell wall compound. Our purpose is to find a way to save the Lascaux cave frescos with an innovating treatment which permit to let the microbiom intact and stop the fungal dispersion on the fresco painting.
+
<b style="font-size:16px;">Conclusions and perspectives</b>
 +
<br><br>
 +
It seems our Gibson step is fine since we managed to obtain the SDP assembly, but we could not get E. coli transformants when performing the whole experience. The predation system is based on the production of toxins by B. subtilis, and these toxins were reported to be harmful to E. coli (Nandy et al., 2007, FEBS Letters. 581: 151–56). An explanation to our problems could be that SDP and SKF cloning in E. coli results in the bacterium death. We had thought about this problem, but we had believed the expression driven by the pVeg Bacillus promoter to be insufficient for such effect. Perspectives could be to use a tightly regulated promoter to prevent expression during the cloning step in E. coli, or to try a direct transformation of highly competent Bacillus strain.
  
<br><br>The first part of our work was to determine the best culture conditions for each tested organisms including our bacteria and all of the fungi strains. We found that the best culture medium containing with ¼ PDA and 2% Glucose. This medium did not permit an optimal bacterial growth but we decided to accept this limit knowing that it will be too much work for such a limited time. Knowing this limit, it is important to note that our results could not be as optimal as expected.
+
</div>
 +
</div>
 +
</div>
 +
 +
  
<br><br>We transformed Bacillus subtilis with two construction : Antifungal A and Antifungal B. They are both large spector antifungal. Our constructions contain the D4E1 and GAFP1 genes which were used by the IGEM team 2014. We decided to use their results as proof of their efficiency. The other antifungal gene are the Dermaseptin b1 gene and the Metchikowin gene (cut or not).
+
 +
<div class="column full_size" id="antifongique" style="background-color:#F5F5F5;">
  
<br><br>We tested our transformed bacteria and their secretome on three different fungi : Aspergillus niger, Talaromyces funiculosus and Chaetomium globosum.
+
<div style="padding-top:30px; padding-left: 10%; padding-right: 10%;">
 +
<div class="hoc container clear">
 +
 +
<b style="font-size:18px;">Antifungals</b>
 +
<br><br>
 +
Here, we aimed to produce a cocktail of five antifungal peptides whose production in Bacillus subtilis will be triggered by presence of fungi.
  
<br><br>The main results were obtained on Talaromyces funiculosus. We observed that with our construction antifungal A an inhibition halo around the patch for the supernatant. These observations allow us to conclude that D4E1 has an effect on fungi and a possible cut metchikowin antifungal effect but we need to try them independently to confirm there antifungal actions. To notice, Metchikowin have also an antibacterial function and might disturb the gram positive bacteria’s growth and the antifungal peptides expression.  
+
<b style="font-size:16px;">Operon constructions:</b>
 +
<br><br>
 +
The whole antifungal operon was too big to be synthesized by IdT as one gblock. We therefore decided to divide it in two operons (figure 5), each of them with a promoter to be functional, with the possibility to eventually combine them. The sequence were optimized for the Bacillus codon usage and to remove inadequate restriction sites. Sub-cloning of the first operon (containing cut version of the Metchnikowin and D4E1) on the pSB1C3 backbone was rapidly performed, leading to the new composite part BBa_K1937007 (pSB1C3-AF_A). However, we did not manage to obtain the second operon in the pSB1C3 (encoding Dermaseptin B1, GAFP-1 and entire Metchnikowin antifungal peptides). We tried to directly sub-clone the gblock in the pSB1C3-AF_A but without success. We hypothesize that one of the peptide could be toxic for E. coli. This will have to be verified by sub-cloning the 3 peptides alone. The AF_A operon was subsequently cloned in the pSBBS0K-mini plasmid to create biobrick BBA_K1937008.
  
<br><br>We did not success to clone our antifungal B construction. We could not test its effect on our fungi target.
+
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 5: Layout of antifungal operons and their assembly.
 +
<br><br>
 +
In order to express specifically the antifungal peptides in close vicinity to fungi, we choose the two N-acetyl-glucosamine (NAG) inducible promotors pNagA and pNagP. The constructions with the RFP reporter gene were ordered from IdT and successfully sub-cloned in the pSB1C3 (new parts BBa_K1937003 and BBa_K1937005 ; figure 6). They were subsequently cloned in the pSBBS0K-mini plasmid to create biobricks BBA_K1937004 and BBa_K1937006.
 +
  
<br><br>Test of the N-acetyl-glucosamine answer :
+
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 6: Layout of the pNag-RFP constructions.
 +
<br><br>
  
<br><br>In order to express specifically the antifungal peptides, we choose two N-acetyl-glucosamine sensitive promotors. We tested their activity with a RFP gene in presence of glucose or N-acetyl-glucosamine. We observed a late and unspecific RFP expression. These promotors need to be optimized. image de test Pnag
+
<b style="font-size:16px;">pNag validation</b>
 +
<br><br>
 +
We tested the expression and specificity of the RFP driven by pNagA and pNagP when growing in presence of glucose or NAG (figure 7). We observed a late and rather specific RFP expression on NAG. The late expression could mean that the formulation of our minimal medium is not optimal. The fact that the pNagA-RFP and pNagP-RFP strains seems able to slightly express the RFP on glucose (figure 7B, left panel close-up), albeit on weaker extend that on NAG (figure 7B, right panel close-up), could be due to the alleviating of the catabolic repression.
 +
<br><br>In conclusion, pNAgA and pNagP appears as able to promote expression in response to NAG, even if the growth conditions could be improved to get higher and more homogeneous expression levels.
  
<br><br>Test on rock :
+
 +
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 7: NAG-driven expression of RFP. B. subtilis strains transformed with pSBBS0K-mini (Control), pSBBS0K-mini-NagA or pSBBS0K-mini-NagP were spread on minimal medium with either glucose or NAG as carbon source. Red GFP spots appeared only with pNagA or pNagP on NAG (close-ups on part 7B).
 +
<br><br>
 +
 +
 +
<b style="font-size:16px;">Antifungal validation</b>
 +
<br><br>
 +
We found out that the best culture conditions for the fungi that permits a slight growth of Bacillus were with ¼ PDA and 2% glucose. We tested different fungi (Aspergillus niger, Talaromyces funiculosus and Chaetomium globosum) but we eventually focussed on Talaromyces funiculosus that seems easier to manipulate to us.
  
<br><br>Even if our project could not be used on the Lascaux cave fresco for now, we decided to test the development of our transformed bacteria on piece of stone covered of painting like the Lascaux cave’s one. We do not have the results for the moment. image des tests sur pierre.  
+
<br><br>Our test consisted in adding, on fungi inoculated plates, paper patches soaked with either copper sulfate (positive control), water (negative control), a suspension of Bacillus subtilis WT or Bacillus subtilis expressing the antifungal AF_A operon (figure 8). We observed that with our construction, a slight inhibition halo appeared around the patch. This effect is visible even after 8 days and was reproducible. These observations allow us to conclude that AF_A is functional.
  
  
 +
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 8: Antifungal tests (legend in the text).
 +
<br><br>
 +
 +
<b style="font-size:16px;">Conclusions and perspectives</b>
 +
<br><br>Here, we showed that our pNagA and NagP parts are able to control gene expression in response to NAG and that the first part of our antifungal operon is functional. In both case, the properties will have to be optimized, through a higher and more homogeneous expression from the NAG-driven promoters and through the completion of the antifungal operons to have more than 2 antifungal peptides.
 +
</div>
 +
</div>
 
</div>
 
</div>
 
 
 
 
 +
<div class="column full_size" id="confinement" style="background-color:#F5F5F5;">
 +
<div style="padding-top:30px; padding-left: 10%; padding-right: 10%;">
 +
<div class="hoc container clear">
 +
 +
<b style="font-size:18px;">Containment</b>
 +
<br><br>
 +
Here, we want a genetic system to prevent horizontal transfer of our synthetic constructions.
 +
 +
<b style="font-size:16px;">Toxin/antitoxine systems constructions</b>
 +
<br><br>
 +
The constructions were ordered as gblocks from IdT. The Epsilon/MazF construction was rapidly sub-cloned in the pSB1C3 backbone (new composite part BBa_K1937007), and then in the pSBBS0K-mini plasmid to create biobricks BBA_K1937008 (figure 9). However, we never managed to get the mazE/Zeta construction in the pSB1C3 backbone. Here again, we can only speculate about the toxicity of the toxin.
 +
 +
 +
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 9: Layout of the toxin/antitoxin operons.
 +
<br><br>
 +
 +
<b style="font-size:16px;">Theophylline validation</b>
 +
<br><br>
 +
To validate the theophylline riboswitch, we reasoned that we should obtain clones of Bacillus subtilis transformed with the pSBBS0K-mini –Epsilon/MazF only in presence of theophylline: the molecule should prevent the expression of the mazF toxin that will be lethal since the antitoxin mazE is not present. Unfortunately, we did not get any clone, neither without nor with theophylline (figure 10).
 +
 +
 +
<!-- ######  FIGURE  ##### -->
 +
<center><img src="" style="width:100%; margin:20px 20px;"></center>
 +
<b>
 +
Figure 10: Result of the Bacillus subtilis transformation with pSBBS0K-mini –Epsilon/MazF (we know this is not the most illustrative figure ever !).
 +
<br><br>
 +
 +
<b style="font-size:16px;">Conclusions and perspectives</b>
 +
<br><br>
 +
At this step, we can only hypothesize that our system is leaking sufficiently the toxins for them to be lethal, either in E. coli or in B. subtilis. Further assays using inducible promoters will be necessary to set up the system without enduring these toxicity problems.
 +
 +
 +
 +
</div>
 
 
 
</html>
 
</html>

Revision as of 13:40, 14 October 2016

iGEM Toulouse 2016

Results

Module Predation

results jknfkjgnfnbnbf


View more

Module Antifungal

Results jkeznfjehvjnrejnregbhjrebgrheb


View more

Module Confinement

Results jkdhferhfrejfhnrejnjhrehjre


View more

Device

Device


View more
Predation

Our aim is to reinforce the natural predation capacity of B. subtilis and to ensure it is constant. We first assessed that our wild type Bacillus chassis is not able of predation, then we built the operons allowing boosting the predation property.

Preliminary tests:

We tried different testing approaches to evaluate the predatory response of B. subtilis and eventually elaborate a protocol to do the preliminary test. We tested the predation of B. subtilis Wild Type against Pseudomonas fluorescens, a deleterious strain present in the cave. Briefly, the protocol consists in growing both strains in rich medium, mixing them in PBS and monitoring their growth (figure 1).
Figure 1: Bacillus subtilis wild type does not feed on Pseudomonas fluorescens. Both strain were grown overnight in rich medium and then mixed in PBS. The growth of both strains were then monitored for 8 hours by plate numeration. The graph represents the ratio between B. subtilis in PBS in presence of P. fluorescens versus B. subtilis alone in PBS (data normalized to time 1H).

We observed no growth benefit when mixing B. subtilis and P. fluorescens versus B. subtilis alone. We conclude that B. subtilis WT predation program is not the strain priority when facing starvation. Other surviving program as competence or sporulation are likely favoured by B. subtilis in such condition. This reinforces the need to prevent these programs by using a spoOA mutant and to promote the predation by overexpressing either the SKF or SDP operons.

SKF

This predation operon is composed of 7 genes for a total of more than 6 Kb. To get rid of restriction sites that could interfere with the cloning steps, we ordered the optimized sequences from IdT as 4 gblocks. From there, our strategy was to do Gibson cloning to obtain the full operon on pSB1C3 in E. coli and then to transfer it in B. subtilis. However, we did not manage to obtain the whole assembly (figure 2), neither partial ones, in spite of about 20 attempts…
Figure 2 : Layout of SKF expected biobrick.

SDP

The SDP operon is smaller than the SKF one and it was possible to obtain the optimized sequences as two gblocks. Here again, we were unfortunate and did not get the expected clones in E. coli (figure 3).
Figure 3 : Layout of SDP expected biobrick.

To perform trouble shooting, we try an assembly test with just the two gblocks and deposited the product on gel. We observed that the reaction seems to be effective with the presence of a new band corresponding to the combined size of the two gblocks (figure 4).
Figure 4: Gibson assemby of the two SDP Gblocks.

Conclusions and perspectives

It seems our Gibson step is fine since we managed to obtain the SDP assembly, but we could not get E. coli transformants when performing the whole experience. The predation system is based on the production of toxins by B. subtilis, and these toxins were reported to be harmful to E. coli (Nandy et al., 2007, FEBS Letters. 581: 151–56). An explanation to our problems could be that SDP and SKF cloning in E. coli results in the bacterium death. We had thought about this problem, but we had believed the expression driven by the pVeg Bacillus promoter to be insufficient for such effect. Perspectives could be to use a tightly regulated promoter to prevent expression during the cloning step in E. coli, or to try a direct transformation of highly competent Bacillus strain.
Antifungals

Here, we aimed to produce a cocktail of five antifungal peptides whose production in Bacillus subtilis will be triggered by presence of fungi. Operon constructions:

The whole antifungal operon was too big to be synthesized by IdT as one gblock. We therefore decided to divide it in two operons (figure 5), each of them with a promoter to be functional, with the possibility to eventually combine them. The sequence were optimized for the Bacillus codon usage and to remove inadequate restriction sites. Sub-cloning of the first operon (containing cut version of the Metchnikowin and D4E1) on the pSB1C3 backbone was rapidly performed, leading to the new composite part BBa_K1937007 (pSB1C3-AF_A). However, we did not manage to obtain the second operon in the pSB1C3 (encoding Dermaseptin B1, GAFP-1 and entire Metchnikowin antifungal peptides). We tried to directly sub-clone the gblock in the pSB1C3-AF_A but without success. We hypothesize that one of the peptide could be toxic for E. coli. This will have to be verified by sub-cloning the 3 peptides alone. The AF_A operon was subsequently cloned in the pSBBS0K-mini plasmid to create biobrick BBA_K1937008.
Figure 5: Layout of antifungal operons and their assembly.

In order to express specifically the antifungal peptides in close vicinity to fungi, we choose the two N-acetyl-glucosamine (NAG) inducible promotors pNagA and pNagP. The constructions with the RFP reporter gene were ordered from IdT and successfully sub-cloned in the pSB1C3 (new parts BBa_K1937003 and BBa_K1937005 ; figure 6). They were subsequently cloned in the pSBBS0K-mini plasmid to create biobricks BBA_K1937004 and BBa_K1937006.
Figure 6: Layout of the pNag-RFP constructions.

pNag validation

We tested the expression and specificity of the RFP driven by pNagA and pNagP when growing in presence of glucose or NAG (figure 7). We observed a late and rather specific RFP expression on NAG. The late expression could mean that the formulation of our minimal medium is not optimal. The fact that the pNagA-RFP and pNagP-RFP strains seems able to slightly express the RFP on glucose (figure 7B, left panel close-up), albeit on weaker extend that on NAG (figure 7B, right panel close-up), could be due to the alleviating of the catabolic repression.

In conclusion, pNAgA and pNagP appears as able to promote expression in response to NAG, even if the growth conditions could be improved to get higher and more homogeneous expression levels.
Figure 7: NAG-driven expression of RFP. B. subtilis strains transformed with pSBBS0K-mini (Control), pSBBS0K-mini-NagA or pSBBS0K-mini-NagP were spread on minimal medium with either glucose or NAG as carbon source. Red GFP spots appeared only with pNagA or pNagP on NAG (close-ups on part 7B).

Antifungal validation

We found out that the best culture conditions for the fungi that permits a slight growth of Bacillus were with ¼ PDA and 2% glucose. We tested different fungi (Aspergillus niger, Talaromyces funiculosus and Chaetomium globosum) but we eventually focussed on Talaromyces funiculosus that seems easier to manipulate to us.

Our test consisted in adding, on fungi inoculated plates, paper patches soaked with either copper sulfate (positive control), water (negative control), a suspension of Bacillus subtilis WT or Bacillus subtilis expressing the antifungal AF_A operon (figure 8). We observed that with our construction, a slight inhibition halo appeared around the patch. This effect is visible even after 8 days and was reproducible. These observations allow us to conclude that AF_A is functional.
Figure 8: Antifungal tests (legend in the text).

Conclusions and perspectives

Here, we showed that our pNagA and NagP parts are able to control gene expression in response to NAG and that the first part of our antifungal operon is functional. In both case, the properties will have to be optimized, through a higher and more homogeneous expression from the NAG-driven promoters and through the completion of the antifungal operons to have more than 2 antifungal peptides.
Containment

Here, we want a genetic system to prevent horizontal transfer of our synthetic constructions. Toxin/antitoxine systems constructions

The constructions were ordered as gblocks from IdT. The Epsilon/MazF construction was rapidly sub-cloned in the pSB1C3 backbone (new composite part BBa_K1937007), and then in the pSBBS0K-mini plasmid to create biobricks BBA_K1937008 (figure 9). However, we never managed to get the mazE/Zeta construction in the pSB1C3 backbone. Here again, we can only speculate about the toxicity of the toxin.
Figure 9: Layout of the toxin/antitoxin operons.

Theophylline validation

To validate the theophylline riboswitch, we reasoned that we should obtain clones of Bacillus subtilis transformed with the pSBBS0K-mini –Epsilon/MazF only in presence of theophylline: the molecule should prevent the expression of the mazF toxin that will be lethal since the antitoxin mazE is not present. Unfortunately, we did not get any clone, neither without nor with theophylline (figure 10).
Figure 10: Result of the Bacillus subtilis transformation with pSBBS0K-mini –Epsilon/MazF (we know this is not the most illustrative figure ever !).

Conclusions and perspectives

At this step, we can only hypothesize that our system is leaking sufficiently the toxins for them to be lethal, either in E. coli or in B. subtilis. Further assays using inducible promoters will be necessary to set up the system without enduring these toxicity problems.



Contacts